Junping F. Zhang

Taiyuan, 030032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Expert consensus on the detection and clinical application of tumor mutational burden.

Expert consensus on the detection and clinical application of tumor mutational burden.

Journal: Cancer biology & medicine

Published: February 18, 2026

Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study.

Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 22, 2025

Subcutaneously Administered Tislelizumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Pharmacokinetics and Safety Results from the BGB-A317-103 Phase I Study.

Subcutaneously Administered Tislelizumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Pharmacokinetics and Safety Results from the BGB-A317-103 Phase I Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 09, 2025

International guidelines on the diagnosis and treatment of NUT carcinoma.

International guidelines on the diagnosis and treatment of NUT carcinoma.

Journal: Innovation (Cambridge (Mass.))

Published: April 11, 2025

Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration.

Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration.

Journal: Cancer biology & medicine

Published: April 09, 2025

Expert Consensus on the Diagnosis and Treatment of FGFR Gene-Altered Solid Tumors.

Expert Consensus on the Diagnosis and Treatment of FGFR Gene-Altered Solid Tumors.

Journal: Global medical genetics

Published: November 25, 2024

Noninvasive early identification of durable clinical benefit from immune checkpoint inhibition: a prospective multicenter study (NCT04566432).

Noninvasive early identification of durable clinical benefit from immune checkpoint inhibition: a prospective multicenter study (NCT04566432).

Journal: Signal transduction and targeted therapy

Published: May 01, 2024

Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations.

Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations.

Journal: Innovation (Cambridge (Mass.))

Published: March 15, 2024

Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid Tumors.

Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid Tumors.

Journal: Global medical genetics

Published: February 28, 2024

Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial.

Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial.

Journal: The Lancet. Respiratory medicine

Published: December 29, 2023

A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.

A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 22, 2023

Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China.

Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China.

Journal: Thoracic cancer

Published: August 23, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026